Page last updated: 2024-08-25

chitosan and Haemophilus Infections

chitosan has been researched along with Haemophilus Infections in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chang, Y; Chen, R; Kang, S; Ma, Y; Qiao, H; Sun, W; Zhang, Y; Zhao, Y	1
Al-Tawil, N; Andersson, M; Binnmyr, J; Enoksson, M; Franzén, H; Gafvelin, G; Grönlund, H; Hällgren, AC; Lafolie, P; Langebäck, J; Lind Enoksson, S; Lindberg, A; Neimert-Andersson, T; Singer, P; Zettergren, L	1
Dai, A; Guo, X; Huang, C; Huang, Q; Li, X; Qiu, GH; Yang, X; Zheng, X	1

Trials

1 trial(s) available for chitosan and Haemophilus Infections

Article	Year
Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial. Vaccine, 2014, Oct-14, Volume: 32, Issue:45 Topics: Adjuvants, Immunologic; Adult; Antibodies, Bacterial; Chitosan; Female; Haemophilus Infections; Haemophilus Vaccines; Humans; Hydrogels; Immunity, Cellular; Interferon-gamma; Male; Middle Aged; Single-Blind Method; Vaccines, Conjugate; Young Adult	2014

Article

Year

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.

Vaccine, 2014, Oct-14, Volume: 32, Issue:45

Topics: Adjuvants, Immunologic; Adult; Antibodies, Bacterial; Chitosan; Female; Haemophilus Infections; Haemophilus Vaccines; Humans; Hydrogels; Immunity, Cellular; Interferon-gamma; Male; Middle Aged; Single-Blind Method; Vaccines, Conjugate; Young Adult

2014

Other Studies

2 other study(ies) available for chitosan and Haemophilus Infections

Article	Year
Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice. PloS one, 2022, Volume: 17, Issue:6 Topics: Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Chitosan; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Immunity, Mucosal; Mannose; Mice; Mice, Inbred BALB C; Microspheres; Nasal Mucosa	2022
Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice. Vaccine, 2017, 03-07, Volume: 35, Issue:10 Topics: Alginates; Animal Structures; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Load; Bacterial Outer Membrane Proteins; Chitosan; Cytokines; Disease Models, Animal; Drug Carriers; Glucuronic Acid; Haemophilus Infections; Haemophilus parasuis; Haemophilus Vaccines; Hexuronic Acids; Immunity, Cellular; Immunity, Humoral; Leukocytes, Mononuclear; Mice, Inbred BALB C; Microspheres; Survival Analysis; Swine; Swine Diseases; Treatment Outcome; Vaccines, Subunit	2017

Article

Year

Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.

PloS one, 2022, Volume: 17, Issue:6

Topics: Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Chitosan; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Immunity, Mucosal; Mannose; Mice; Mice, Inbred BALB C; Microspheres; Nasal Mucosa

2022

Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.

Vaccine, 2017, 03-07, Volume: 35, Issue:10

Topics: Alginates; Animal Structures; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Load; Bacterial Outer Membrane Proteins; Chitosan; Cytokines; Disease Models, Animal; Drug Carriers; Glucuronic Acid; Haemophilus Infections; Haemophilus parasuis; Haemophilus Vaccines; Hexuronic Acids; Immunity, Cellular; Immunity, Humoral; Leukocytes, Mononuclear; Mice, Inbred BALB C; Microspheres; Survival Analysis; Swine; Swine Diseases; Treatment Outcome; Vaccines, Subunit

2017